Alendronate (Fosamax, Fosamax Plus D, and generic), the first bisphosphonate approved by the Food and Drug Administration for the treatment and prevention of osteoporosis, came on the market in 1995 and proved to be a moneymaker, bringing in nearly $3.2 billion in 2005.
http://www.consumerreports.org/cro/2012/04/popular-osteoporosis-drugs-come-with-mounting-concerns/index.htm
The safety of Reclast in the treatment of postmenopausal osteoporosis was assessed in Study 1, a large, randomized, double-blind, placebo-controlled, multinational study of 7736 postmenopausal women aged 65 to 89 years with osteoporosis, diagnosed by bone mineral density or the presence of a prevalent vertebral fracture.
https://www.drugs.com/pro/reclast.html
Many people who use corticosteroids, such as prednisone, also can lose bone mass. Reclast treats osteoporosis by stopping particular chemicals that cause the bone to break down, which slows the process of deterioration. It also helps bones retain more calcium. Reclast is given once a year and sometimes once every two years.
https://www.sharecare.com/health/calcium-regulator/how-reclast-treat-osteoporosis
Reclast Infusion: New Treatment, Old Story. As so often happens with new osteoporosis drugs – and Reclast infusion is a fairly new treatment – the truth becomes shrouded as pharmaceutical companies make grabs for money, power, recognition, and more money. The humble osteoporosis patient gets lost in the proverbial shuffle.
https://saveourbones.com/reclast-infusion-new-treatment-old-story/
Prevention of Osteoporosis in Postmenopausal Women. Reclast is indicated for prevention of osteoporosis in postmenopausal women [see Clinical Studies (14.2)]. Osteoporosis in Men. Reclast is indicated for treatment to increase bone mass in men with osteoporosis [see Clinical Studies (14.3)].
https://www.drugs.com/pro/reclast.html
With age, some diseases, and as a consequence of treatment for some diseases, the formation of new bone is drammatically slowed. Reclast, and the other bisphosphinates, slow down the breakdown of bone. This results in overall more bone mass and less bone fractures.
https://www.sharecare.com/health/calcium-regulator/how-reclast-treat-osteoporosis
Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, diagnosed by bone mineral density (BMD) or prevalent vertebral fracture, Reclast reduces the incidence of fractures (hip, vertebral and non-vertebral osteoporosis-related fractures).
https://www.drugs.com/pro/reclast.html
– August 19, 2008. Reclast is the latest drug introduced to treat osteoporosis. Unlike earlier drugs of the same type – Fosamax, Actonel and Boniva – Reclast has not been approved for prevention of osteoporosis. But like the approved drugs, it is a bisphosphonate, a class of drugs that works by slowing bone breakdown.
https://www.drweil.com/health-wellness/body-mind-spirit/bone-joint/reclast-is-annual-treatment-better-for-bones/
There is also the once-a-year injection drug, zoledronic acid (Reclast, Zometa). But research has found that bisphosphonates offer only modest benefits in building bone and preventing fractures. And all pose risks. Growing evidence has now linked the drugs to a long list of worrisome side effects.
http://www.consumerreports.org/cro/2012/04/popular-osteoporosis-drugs-come-with-mounting-concerns/index.htm
That success likely contributed to the introduction of several related drugs to treat osteoporosis, including some in more convenient doses, such as the heavily advertised ibandronate (Boniva), which can be taken orally just once a month or intravenously once every three months.
http://www.consumerreports.org/cro/2012/04/popular-osteoporosis-drugs-come-with-mounting-concerns/index.htm
what does reclast treat
Reclast is indicated for treatment of osteoporosis in postmenopausal women.